ESTÜDAM Halk Sağlığı Dergisi
Yazarlar: Sevil Akbulut ZENCİRCİ, Selma METİNTAŞ
Konular:-
Anahtar Kelimeler:Malaria,Vaccine,Pre-Erythrocytic Vaccine,Blood-Phase Vaccine,VaccinePreventing Vaccine
Özet: Malaria continues to be a major public health problem in tropical regions. In the struggling against malaria, significant achievements have been obtained with the spread of present malaria control precautions since 2000. Hovewer causes such as existing areas limited access to these precautions and insecticide and multidrug resistance exhibits an effective vaccine against malaria is required for struggling and eliminating malaria. RTS, S / AS01 is only vaccine at phase 3 evaluation has been done and planned to do pilot impelementation and the vaccine is 5-10 years ahead than other vaccines. Understanding and eliminating possible deficiencies with pilot implementation, and if necessary combining with other precautions will contribute the elimination goal. If the trend in declining malaria morbidity and mortality continues, it is likely that research will be directed to P. vivax in coming years